Lumykras : EPAR - Risk management plan
Lumykras : EPAR - Risk management plan
Lumykras : EPAR - Risk management plan
Agenda of the CVMP meeting 3-5 December 2024
Record of data processing activity for the Experts Management Tool and the handling of competing interests
Expected publication dates of PRAC recommendations on safety signals
Metamizole
Orphan designation: Human monoclonal IgG1 antibody against tissue factor pathway inhibitor Treatment of haemophilia A, 14/10/2016 Withdrawn
Human medicines European public assessment report (EPAR): Tavlesse, fostamatinib, Date of authorisation: 09/01/2020, Revision: 6, Status: Authorised
Tavlesse : EPAR - Risk management plan
PSUSA/00002204/202404
Human medicines European public assessment report (EPAR): Dabigatran etexilate Teva (previously Dabigatran etexilate Leon Farma), dabigatran etexilate, Date of authorisation: 19/02/2024, Revision: 3, Status: Authorised